JONATHAN MARTIN: Open Payments
NPI 1174908230 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 84 payments from 13 companies in 2025. Trend: 2023 $152 · 2024 $857 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 33 | $511 |
| Neurocrine BioSciences, Inc. | 11 | $190 |
| ABBVIE INC. | 11 | $153 |
| Vanda Pharmaceuticals Inc. | 6 | $141 |
| Teva Pharmaceuticals USA, Inc. | 7 | $126 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Biogen, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
Products named: ARISTADA, INGREZZA, VRAYLAR, UZEDY, HETLIOZ, CAPLYTA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across KY — which companies pay providers there.
